Dr. Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company committed to providing access to affordable and innovative medicines. We are driven by our purpose of 'Good Health Can't Wait'.
We offer a comprehensive portfolio of products and services including Active Pharmaceutical Ingredients, generics, branded generics, biosimilars and over-the-counter pharmaceutical products across the world.
Our therapeutic areas are focused on gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
We are present in 74 countries including North America, India, Russia CISR, China, and Europe. We leverage our research and development expertise, end-to-end manufacturing know-how and progressive digital technology to deliver on our promises to patients around the world.
DRL Philippines Inc was formed in 2018 as local subsidiary. Our goal is to provide access to advance and innovative medicines to the Filipinos with major focus in the management of cancer and other critical ailments.